The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American College of Clinical Pharmacy is approved by BPS as a provider for the recertification of BCPS.
BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/
To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.
The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.
In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.
The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.
Target Audience: The target audience for Clinical Reasoning Series in Pharmacotherapy is the pharmacist practicing in a clinical setting as a Board-Certified Pharmacotherapy Specialist (BCPS), looking to earn recertification credit, and those clinicians seeking additional information on the topics covered.
Sex, Drugs, and Risk Reduction: Discussing and Debating Estrogen and Testosterone in 2026 Activity Number: 0217-0000-26-112-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning Objectives
1. Critique key historical studies contributing to conflicting perspectives on cardiovascular risk with testosterone therapy.
2. Reconcile discordance between public policy and clinical practice guidelines on testosterone therapy with emerging literature.
3. Formulate evidence-based and patient-centered testosterone therapy recommendations reflective of the latest evidence on cardiovascular risks and benefits.
4. Compare the results and context of the original Women’s Health Initiative studies to the application of studies today.
5. Organize a list of indications for menopausal hormone therapy based on the strength of evidence to support the indications.
6. Given patient specific menopausal symptoms, design an evidence-based person-centered care plan for symptom control.
|
Heated Rival-Rx: Opportunities and Interventions in Sports PharmacyActivity Number: 0217-0000-26-113-H99-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning Objectives
1. Interpret key anti-doping rules relevant to clinical pharmacists.
2. Describe athlete experiences and expectations surrounding anti-doping regulations.
3. Evaluate use of prohibited substances and methods.
4. Show resources available to pharmacists providing care to patient-athletes.
5. Assess how pharmacists can help athletes apply for therapeutic use exemptions.
6. Recommend appropriate supplement use for athletes through evidence-based evaluation of risks and benefits.
|
Skin in the Game: Burn and Wound Pharmacotherapy UpdatesActivity Number: 0217-0000-26-114-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning Objectives
1. Determine burn injury severity by assessing the size and depth of injury.
2. Recommend an appropriate burn resuscitation strategy for a patient with a large body surface area burn.
3. Compare pharmacokinetic alterations after burn injury to patients without burns.
4. Select topical antimicrobial therapies based on wound characteristics, infection risk, and patient-specific factors.
5. Construct a multimodal analgesic regimen for a patient with a large body surface area burn.
6. Recognize drug-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) to initiate appropriate therapy.
|
Beyond the Counter and Into the Crisis: Pharmacist Roles in Disaster ResponseActivity Number: 0217-0000-26-115-H99-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning Objectives
1. Categorize disasters, communicable disease outbreaks, and mass casualty events by their impact on pharmaceutical care and pharmacist involvement opportunities.
2. Identify resources for education and training on preparedness, disaster response frameworks, and certifications that can enhance individual clinical pharmacist readiness.
3. Evaluate disaster response medication management strategies using evidence-based frameworks to determine applicability across pharmacy practice settings.
4. Formulate disaster response plans, policies and procedures, and protocols for your organization and/or practice site.
5. Apply disaster response readiness skills in different clinical scenarios.
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.